Innophos Holdings, Inc. Securities Litigation

If you purchased a significant amount of shares of Innophos Holdings, Inc. (NASDAQ: IPHS), you have certain options. Investors should contact us.

 

Lawsuit Overview

Defendant:Innophos Holdings, Inc.
Date Filed:November 25th, 2019
Sector:Consumer Durables
Industry:Specialty Chemicals

According to the Complaint, Innophos is a leading international producer of essential ingredients.

This action stems from a proposed transaction announced on October 21, 2019, pursuant to which Innophos Holdings, Inc. will be acquired by Iris Parent LLC and Iris Merger Sub 2019, Inc., which are affiliates of One Rock Capital Partners, LLC.

On October 20, 2019, Innophos's Board of Directors caused the Company to enter into an agreement and plan of merger with One Rock. Pursuant to the terms of the Merger Agreement, Innophos's stockholders will receive $32.00 in cash for each share of Innophos common stock they own.

On November 14, 2019, Defendants filed a proxy statement with the United States Securities and Exchange Commission in connection with the Proposed Transaction. The Complaint alleges that the Proxy Statement omits material information with respect to the Proposed Transaction, which renders the Proxy Statement false and misleading.


Sign up for free to create a personalized portfolio with tracking and e-mail alerts for Innophos Holdings, Inc.

 
First Identified Complaint

Michael Kent, et al. v. Innophos Holdings, Inc., et al.

Date Filed:November 25th, 2019
Class Period Start:October 21st, 2019
Class Period End:November 25th, 2019
First Identified Complaint Filings
#Document TitleFiling Date